Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 2,035.00
-350.00 (-14.68%)
At close: Aug 21, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 7.28 billion as of August 21, 2026. Its market cap has decreased by -50.24% in one year.
Market Cap
7.28B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
6.19
Stock Price
2,035.00
ChartMarket Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 7.28B, a decrease of -69.11%. That is a compound annual growth rate of -33.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 7.28B | -42.84% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Baskhanbio Pharma | 25.27B |
| Daesung Microbiological Labs. | 23.45B |
| Seoul Pharma | 23.23B |
| BIFIDO | 22.33B |
| Hurum | 21.70B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 18.09B |
| ChoA Pharmaceutical Co., LTD. | 17.04B |